PPARGC1A and breast carcinoma: The mRNA expression levels of FABP4, ADIPOQ, PPARG, CD36, and PPARGC1A were significantly lower in patients with breast cancer (Fig. 6A), whereas the mRNA levels of CREBBP were not different between patients with breast cancer and normal breast tissues.